BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 4037825)

  • 1. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
    Lafond G; Roy PE; Grenier R
    Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen--long-wave ultraviolet therapy and human cataractogenesis.
    Lerman S; Megaw J; Gardner K
    Invest Ophthalmol Vis Sci; 1982 Dec; 23(6):801-4. PubMed ID: 7141823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Could PUVA therapy and solar lights provoke ocular lesions?].
    De Witte E; Coppens A; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 185():111-7. PubMed ID: 540187
    [No Abstract]   [Full Text] [Related]  

  • 5. A retrospective study of cataract formation in 96 patients treated with PUVA.
    Hammershøy O; Jessen F
    Acta Derm Venereol; 1982; 62(5):444-6. PubMed ID: 6183901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PUVA treatment and the problem of ocular damage (author's transl)].
    Lerman S; Koch HR
    Klin Monbl Augenheilkd; 1981 May; 178(5):347-9. PubMed ID: 7253523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
    Bond CA; Grant K; Boh L
    Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemotherapy and the eye: photoprotective factors.
    Glew WB; McKeever G; Roberts WP; Malinin G; Nigra TP
    Trans Am Ophthalmol Soc; 1980; 78():243-54. PubMed ID: 7257058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralens and ocular effects in humans.
    Glew WB; Nigra TP
    Natl Cancer Inst Monogr; 1984 Dec; 66():235-9. PubMed ID: 6531036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light.
    Greene I; Cox AJ
    Arch Dermatol; 1979 Oct; 115(10):1200-2. PubMed ID: 507862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study.
    Malanos D; Stern RS
    J Am Acad Dermatol; 2007 Aug; 57(2):231-7. PubMed ID: 17532094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
    Roelandts R
    Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
    Dayal S; ; Jain VK
    Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular phototoxicity and psoralen plus ultraviolet radiation (320-400 nm) therapy: an experimental and clinical evaluation.
    Lerman S
    J Natl Cancer Inst; 1982 Jul; 69(1):287-302. PubMed ID: 6285062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin cancer in patients treated with 8-methoxypsoralen plus longwave ultraviolet radiation.
    Halprin KM; Comerford M; Taylor JR
    Natl Cancer Inst Monogr; 1984 Dec; 66():185-9. PubMed ID: 6531027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
    Boer J; Hermans J; Schothorst AA; Suurmond D
    Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestations.
    Lerman S
    Natl Cancer Inst Monogr; 1984 Dec; 66():227-33. PubMed ID: 6531035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myelomonocytic leukaemia developing in a patient with psoriasis treated with oral 8-methoxypsoralen and longwave ultraviolet light.
    Freeman K; Warin AP
    Clin Exp Dermatol; 1985 Mar; 10(2):144-6. PubMed ID: 3856495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.